Cargando…

The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectives

Trastuzumab was the first targeted therapy for HER2 positive breast cancer. It has become the standard of care for HER2 positive metastatic breast cancer since 2000 and in the adjuvant setting since 2006. Adjuvant it is given for a year and in patients with metastatic disease until progression. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadmitriou, K., Trinh, X.B., Altintas, S., Van Dam, P.A., Huizing, M.T., Tjalma, W.A.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Universa Press 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788333/ https://www.ncbi.nlm.nih.gov/pubmed/26977267

Ejemplares similares

The smooth and bumpy road of trastuzumab administration: from intravenous (IV) in a hospital to subcutaneous (SC) at home
por: Tjalma, WAA, et al.
Publicado: (2017)

A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer
por: Van Berckelaer, C., et al.
Publicado: (2020)

A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium
por: Tjalma, W.A.A., et al.
Publicado: (2015)

Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
por: Waller, Cornelius F., et al.
Publicado: (2021)

Current view on ductal carcinoma in situ and importance of the margin thresholds: A review
por: Van Cleef, A., et al.
Publicado: (2014)

Benchmarking and audit of breast units improves quality of care
por: van Dam, P.A., et al.
Publicado: (2013)

Reimbursement for bone loss prevention is different between women with breast cancer and men with prostate cancer: time for a revision
por: Tjalma, W.A.A.
Publicado: (2015)

Is anti-hormonal treatment in DCIS of the breast a need?
por: Tjalma, WAA
Publicado: (2016)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment
por: van Dam, Peter A., et al.
Publicado: (2015)

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review
por: Kolberg, Hans-Christian, et al.
Publicado: (2021)

HPV vaccination coverage in the federal state of Belgium according to regions and their impact
por: Tjalma, WAA, et al.
Publicado: (2018)

Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients
por: Farolfi, Alberto, et al.
Publicado: (2017)

Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study
por: Simoens, Steven, et al.
Publicado: (2021)

Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain
por: Lopez-Vivanco, G., et al.
Publicado: (2017)

A clitoral verrucous carcinoma in an area of lichen planus has aggressive features
por: Tjalma, Wiebren A. A., et al.
Publicado: (2017)

A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer
por: De Cock, Erwin, et al.
Publicado: (2016)

On the Subcutaneous Injection of Blood, Infusion (Subcutaneous) and Intravenous Transfusion
por: Oehler,, et al.
Publicado: (1888)

Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden
por: Hedayati, Elham, et al.
Publicado: (2019)

Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer
por: Rojas, Luis, et al.
Publicado: (2020)

Postgraduate cadaver surgery: An educational course which aims at improving surgical skills
por: Tjalma, W.A.A., et al.
Publicado: (2013)

Association of socio-economic status with family history in adult patients with asthma
por: Davoodi, Parisa, et al.
Publicado: (2013)

Survey: acceptability of opportunistic bilateral salpingectomy in Flanders
por: Maryns, A.S., et al.
Publicado: (2021)

SARS-CoV-2 and cancer: Are they really partners in crime?
por: van Dam, Peter A., et al.
Publicado: (2020)

The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review
por: Van den Nest, Miriam, et al.
Publicado: (2019)

Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab
por: De Sanctis, Rita, et al.
Publicado: (2021)

Quality of care in the course of subcutaneous versus intravenous trastuzumab administration in patients with breast cancer: an integrated time–motion study with mixed-methods research
por: Lin, Hsiang-Wen, et al.
Publicado: (2023)

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
por: Lokhandwala, Tasneem, et al.
Publicado: (2021)

Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients
por: Prasad, Bhanu, et al.
Publicado: (2020)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018)

Mycosis fungoides of the vulva
por: Tjalma, Wiebren A. A., et al.
Publicado: (2020)

Socio-Economic Impact
por: Florio, Massimo, et al.
Publicado: (2023)

Exposure to Hookah and Cigarette Smoke in Children and Adolescents According to Their Socio-Economic Status: The CASPIAN-IV Study
por: Kelishadi, Roya, et al.
Publicado: (2016)

Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, A, et al.
Publicado: (2013)

Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
por: Najim, Omar, et al.
Publicado: (2023)

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
por: Joona, Therse Björkin, et al.
Publicado: (2020)

SC RFQ engineering desgin revised
por: Bisoffi, G, et al.
Publicado: (23/0)

Demographic and socio-economic predictors of physical activity among people living with HIV of low socio-economic status
por: Mabweazara, Smart Z., et al.
Publicado: (2019)

The rationale of opportunistic bilateral salpingectomies (OBS) during benign gynaecological and obstetric surgery: a consensus text of the Flemish Society of Obstetrics and Gynaecology (VVOG)
por: Tjalma, WAA, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_119j41lmtdap2cps6fo8rdnrb5